Articles Archives - Immusoft

Investors & Media

Articles

From Awareness to Acceleration: Rare Disease Drug Development Enters a Pivotal Era

February 4, 2026

BioSpace
Articles

Fast-Tracked CGT Platform Eliminates Patient Preconditioning

January 13, 2026

Genetic Engineering & Biotechnology News
Articles

Immusoft Goes For Cell Therapy Plan ‘B’

February 26, 2025

Citeline
Articles

Immusoft Reports Promising Early Data for Lead Candidate in MPS I

October 17, 2024

Genetic Engineering & Biotechnology News
Articles

First patient who received engineered B cell therapy sees early promise for MPS I

October 15, 2024

Endpoints News
Articles

B cells as drug factories

June 17, 2024

Nature Biotechnology
Articles

In a World First, a Patient’s Antibody Cells Were Just Genetically Engineered

December 15, 2023

Wired
Articles

A new gene therapy based on antibody cells is about to be tested in humans

September 1, 2022

MIT Technology Review
Articles

Takeda to Work With Immusoft in $900 Million Rare-Disease Deal

October 13, 2021

Bloomberg
Articles

Drawn to the idea of turning B cells into ‘protein factories,’ Takeda jumps into a milestone-heavy, $900M pact

October 13, 2021

Endpoints News